Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Arkadiusz Z. Dudek

Dr. Arkadiusz Z. Dudek


Dr. Arkadiusz Z. Dudek is a leading medical oncologist at Regions Hospital Cancer Care Center in St. Paul, Minnesota. He has written several research papers on tumor biology and targeted cancer therapies. Dudek also has more than 100 publishing credits in peer-reviewed medical oncology journals.

Get in touch
Jump to a Topic:

About Arkadiusz Z. Dudek

  • Pleural and Lung Cancer icon

    Pleural Mesothelioma

  • Immunotherapy icon


  • Research Excellence icon

    Excellence in Research

  • Board Certified icon

    Board Certified in Medical Oncology

Get to Know Dr. Arkadiusz Z. Dudek

Dr. Arkadiusz Dudek started the Metro-Minnesota Community Oncology Research Consortium, which includes an early-phase clinical trial program. He aims to uncover and develop new therapies for a variety of cancers, including malignant pleural mesothelioma.

He is currently the principal investigator in many clinical trials involving pleural mesothelioma treatment. One of those trials is exploring the synergistic effect of immunotherapy drugs, such as nivolumab (Opdivo) and ramucirumab (Cyramza), for previously treated mesothelioma patients.

Dudek has been interested in cancer’s molecular and cellular biology since graduating from the Medical University of Warsaw in 1989. He completed his residency in internal medicine at the Pinnacle Health Hospitals in Harrisburg, Pennsylvania. His fellowship in oncology and hematology was at the University of Minnesota.

He then spent four years at the University of Illinois College of Medicine in Chicago. There, he developed another highly regarded cancer research program before returning to Minnesota in 2016. The number of cancer patients who came to him throughout his career after undergoing failed chemotherapy has always inspired Dudek.

“Patients were coming with a hope to find a better treatment that targeted their cancer,” he told The Mesothelioma Center at “The only way to give them hope or a chance at surviving was to look to experimental therapeutics. Finding something new and innovative became my motivation.”

Specialties of Dr. Arkadiusz Dudek

Dr. Arkadiusz Dudek’s Experience and Medical Education

  • Medical University of Warsaw, Poland (M.D.)

  • Pinnacle Health Hospitals (Internal medicine residency)

  • University of Minnesota (Hematology and oncology fellowship)

Awards and Certifications for Dr. Arkadiusz Dudek

  • American Board of Internal Medicine (Certification)

  • American Board of Internal Medicine — Hematology (Certification)

  • American Board of Internal Medicine — Medical Oncology (Certification)

Mesothelioma Clinical Trials Under Arkadiusz Dudek, M.D.

  • Anti-programmed death — Ligand 1 antibody, MEDI4736, in combination with chemotherapy for the first-line treatment of unresectable mesothelioma.

  • Phase Ib and phase II studies of anti-PD-1 antibody MK-3475 in combination with bevacizumab for the treatment of metastatic renal cell carcinoma: Big Ten Cancer Research Consortium BTCRC-GU14-003.

  • Phase II study of nivolumab and ramucirumab for patients with previously treated mesothelioma: HCRN LUN15-299.

  • A phase I/II trial of X4P-001 as a single agent and in combination with axitinib in patients with advanced renal cell carcinoma.

  • A phase III study of androgen annihilation in high-risk biochemically relapsed prostate cancer.

See More Top Mesothelioma Doctors

Publications of Dr. Arkadiusz Dudek

Disclaimer: Dr. Arkadiusz Z. Dudek has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at
Edited by

2 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. (n.d.). Arkadiusz Z. Dudek, MD.
    Retrieved from:
  2. (n.d.). Arek Z. Dudek, MD, PhD.
    Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified October 15, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now